Test Lists

  • Regression Package Testing List Page
Publisher QA3 - UPP Test
  • Regression Package Testing List Page
1 / 0

Curis to Present at H.C. Wainwright & Co. 6th Annual Israel Conference

November 4, 2020
By Curis, Inc.;H.C. Wainwright & Co.;
Alt Text FF - Home Screen Icon 3
Caption FF
Description FF
Share this...
  • Facebook
  • Pinterest
  • Twitter
  • Linkedin

LEXINGTON, Mass., Nov. 4, 2020 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that James Dentzer, President and Chief Executive Officer of Curis, will present at the H.C. Wainwright & Co. 6th Annual Israel Conference on Thursday, November 12, 2020 at 12:00 pm ET.

A live webcast of the presentation will be available under “Events & Presentations” in the Investors section of the Company’s website at www.curis.com. A replay of the webcast will be available on the Curis website for 90 days following the event.

About Curis, Inc.

Curis is a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer. In 2015, Curis entered into a collaboration with Aurigene in the areas of immuno-oncology and precision oncology. As part of this collaboration, Curis has exclusive licenses to oral small molecule antagonists of immune checkpoints including, the VISTA/PDL1 antagonist CA-170, and the TIM3/PDL1 antagonist CA-327, as well as the IRAK4 kinase inhibitor, CA-4948. CA-4948 is currently undergoing testing in a Phase 1 trial in patients with non-Hodgkin lymphoma and in a Phase 1 trial in patients with acute myeloid leukemia and myelodysplastic syndromes. In addition, Curis is engaged in a collaboration with ImmuNext for development of CI-8993, a monoclonal anti-VISTA antibody, which is currently undergoing testing in a Phase 1a/1b trial in patients with solid tumors. Curis is also party to a collaboration with Genentech, a member of the Roche Group, under which Genentech and Roche are commercializing Erivedge® for the treatment of advanced basal cell carcinoma. For more information, visit Curis’ website at www.curis.com. 

 

Categories: Madison Magazine Logo

Latest Stories

Eu Regulator Authorizes Astrazeneca Vaccine For All Adults

EU regulator authorizes AstraZeneca vaccine for all adults

Rayos Syndication User,
KXLY-Latest Stories

Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.

Ex Fbi Lawyer Given Probation For Russia Probe Actions

Ex-FBI lawyer given probation for Russia probe actions

Rayos Syndication User,
KXLY-Latest Stories

WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.

Evers: Repealing Mask Mandate Like Eliminating Speed Limits

Evers: Repealing mask mandate like eliminating speed limits

Rayos Syndication User,
KXLY-Latest Stories

MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.

Conservatives Praise South Carolina Win On Abortion Ban

Conservatives praise South Carolina win on abortion ban

Rayos Syndication User,
KXLY-Latest Stories

COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.

Moscow Court Puts Navalny’s Allies Under House Arrest

Moscow court puts Navalny's allies under house arrest

Rayos Syndication User,
KXLY-Latest Stories

A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.

Most Popular

9:40 Future Import Test

One more current test NW

Current UPP Import NW

Test New Article 12092025 - 4 - Message

Test New Article 12092025 - 4 - Election

Test New Article 12092025 - 2 - Closing

© 2026 Publisher QA3 – UPP Test.

Privacy Policy
Powered byBLOX Digital
X